SLC7A13 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-10159
Key Product Details
Species Reactivity
Validated:
Rat
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Summary for SLC7A13 Antibody
Immunogen
The immunogen is a synthetic peptide directed towards the N terminal region of rat SLC7A13 (NP_001012100). Peptide sequence MAMDIEKKIYLKRQLGYFWGTNFLIINIIGAGIFVSPKGVLQYSSMNVGV
Clonality
Polyclonal
Host
Rabbit
Theoretical MW
54 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Scientific Data Images for SLC7A13 Antibody
Western Blot: SLC7A13 Antibody [NBP3-10159]
Western Blot: SLC7A13 Antibody [NBP3-10159] - Western blot analysis of SLC7A13 in Rat Skeletal Muscle lysates. Antibody dilution at 1ug/mlApplications for SLC7A13 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: SLC7A13
Alternate Names
AGT1, AGT-1, solute carrier family 7 (anionic amino acid transporter), member 13, solute carrier family 7 member 13, XAT2
Gene Symbol
SLC7A13
Additional SLC7A13 Products
Product Specific Notices for SLC7A13 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...